ITPR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.734600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.335800E-01
Normal-vs-Stage2
3.625600E-01
Normal-vs-Stage3
2.927800E-01
Normal-vs-Stage4
4.072000E-01
Stage1-vs-Stage2
4.791800E-01
Stage1-vs-Stage3
1.299220E-01
Stage1-vs-Stage4
8.098400E-01
Stage2-vs-Stage3
4.177200E-01
Stage2-vs-Stage4
7.234400E-01
Stage3-vs-Stage4
1.638250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.762000E-01
Normal-vs-AfricanAmerican
2.322000E-01
Normal-vs-Asian
3.000600E-01
Caucasian-vs-AfricanAmerican
7.475000E-01
Caucasian-vs-Asian
1.852190E-01
AfricanAmerican-vs-Asian
2.660800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.567200E-01
Normal-vs-Female
3.983200E-01
Male-vs-Female
2.198200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.042600E-01
Normal-vs-Age(41-60Yrs)
4.047000E-01
Normal-vs-Age(61-80Yrs)
3.668800E-01
Normal-vs-Age(81-100Yrs)
3.086600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.882200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.286400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.090780E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.375800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.149500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.218760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.170200E-01
Normal-vs-Daily Drinker
3.027000E-01
Normal-vs-Weekly Drinker
3.347400E-01
Normal-vs-Occasional Drinker
3.568400E-01
Normal-vs-Social Drinker
1.662560E-01
Non Drinker-vs-Daily Drinker
7.074400E-01
Non Drinker-vs-Weekly Drinker
7.364000E-01
Non Drinker-vs-Occasional Drinker
3.939400E-01
Non Drinker-vs-Social Drinker
1.589220E-01
Daily Drinker-vs-Weekly Drinker
4.784600E-01
Daily Drinker-vs-Occasional Drinker
1.996770E-01
Daily Drinker-vs-Social Drinker
1.065820E-01
Weekly Drinker-vs-Occasional Drinker
6.654800E-01
Weekly Drinker-vs-Social Drinker
2.542200E-01
Occasional Drinker-vs-Social Drinker
3.685600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.645000E-01
Normal-vs-Grade 2
3.218800E-01
Normal-vs-Grade 3
4.109800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.219400E-01
Grade 1-vs-Grade 3
8.914200E-02
Grade 1-vs-Grade 4
3.645000E-01
Grade 2-vs-Grade 3
3.110400E-01
Grade 2-vs-Grade 4
3.218800E-01
Grade 3-vs-Grade 4
4.109800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.854200E-01
Normal-vs-NonDiabetic
3.468400E-01
Diabetic-vs-NonDiabetic
3.509200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.005000E-01
Normal-vs-NoPancreatitis
3.622200E-01
Pancreatitis-vs-NoPancreatitis
2.547600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.930600E-01
Normal-vs-N1
3.632800E-01
N0-vs-N1
5.343000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.679400E-01
Normal-vs-TP53-NonMutant
4.405200E-01
TP53-Mutant-vs-TP53-NonMutant
2.025600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
